Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing oxycodone and sufentanil for pain and inflammatory response after transarterial chemoembolization in hepatocellular carcinoma has been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone (oxycodone)
  • Sufentanil (sufentanil)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization | Phase 4 | Status: COMPLETED